06/01/2026
Harlequin Ichthyosis – A Rare and Challenging Congenital Disorder
Harlequin ichthyosis (HI) is the most severe form of autosomal recessive congenital ichthyosis, with an incidence of approximately 1 in 300,000 live births.
Genetic Basis
Caused by biallelic mutations in the ABCA12 gene, which impairs lipid transport in keratinocytes, leading to defective skin barrier formation.
Clinical Presentation at Birth
- Thick, rigid, plate-like hyperkeratotic skin with deep erythematous fissures (“harlequin” appearance)
- Severe ectropion (everted eyelids) and eclabium (everted lips)
- Restricted limb movement and joint contractures
- Flattened ears and nose
- High risk of: – Transcutaneous fluid and heat loss – Sepsis (due to barrier disruption) – Respiratory distress (chest restriction or aspiration)
Immediate Neonatal Management
Multidisciplinary care is essential:
- Humidified incubator to prevent dehydration
- Gentle mechanical debridement and frequent application of emollients
- Ophthalmic lubricants for ectropion protection
- Infection surveillance and early antibiotics if needed
- Nutritional support (high-calorie feeds)
- Oral retinoids (e.g., acitretin) often initiated early to promote shedding of hyperkeratotic plates
Long-Term Care
- Ongoing intensive emollient therapy
- Multidisciplinary follow-up (dermatology, ophthalmology, physiotherapy, psychology)
- Risk of recurrent infections, overheating, and growth issues
Prognosis
Historically fatal in the neonatal period, survival has dramatically improved with modern intensive care — many individuals now live into adulthood with good quality of life.
Key Nursing Role
Compassionate, meticulous skin care and family education are pivotal. Support parents through the initial shock and empower them for lifelong management.
Early diagnosis (possible via prenatal ultrasound or genetic testing) and prompt specialised care save lives.
# keybet medical biochemist